Matteo S. Pizzuto
Bellinzona, TI, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Potent efficacy of an NA-targeting antibody against a broad spectrum of H5N1 influenza viruses.
Journal: Nature communications
Published: February 10, 2025
A potent pan-sarbecovirus neutralizing antibody resilient to epitope diversification.
Journal: Cell
Published: February 28, 2024
Author Correction: A pan-influenza antibody inhibiting neuraminidase via receptor mimicry.
Journal: Nature
Published: July 05, 2023
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages.
Journal: Science (New York, N.Y.)
Published: October 20, 2022
A pan-influenza antibody inhibiting neuraminidase via receptor mimicry.
Journal: Nature
Published: September 19, 2022
Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies.
Journal: Nature
Published: July 21, 2022
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages.
Journal: bioRxiv : the preprint server for biology
Published: June 09, 2022
Transcytosis of IgA Attenuates Salmonella Invasion in Human Enteroids and Intestinal Organoids.
Journal: Infection and immunity
Published: May 17, 2022
Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry.
Journal: Science (New York, N.Y.)
Published: January 06, 2022
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.
Journal: bioRxiv : the preprint server for biology
Published: December 21, 2021
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity.
Journal: Nature
Published: December 21, 2021
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.
Journal: Nature
Published: December 12, 2021
Last Updated: 09/26/2026